Mr. Sriram Ramanathan serves as Chief Executive Officer at Nevakar. He also serves as Board Member at Endoluxe. He is a Pharmacist by education with over 20 years of experience in the pharmaceutical industry. Mr. Ramanathan has a Master's degree in Pharmaceutical Sciences and a Master's degree in Business Administration. Prior to joining Nevakar, LLC, Mr. Ramanathan was the Chief Operating Officer at InnoPharma, Inc. a pharmaceutical development company focused on the development of complex generic sterile products. He continued with InnoPharma as Executive Director, Operating Officer after the acquisition of the company by Pfizer, Inc. in September 2014 and left InnoPharma, Inc. - a Pfizer Company in November 2015. Mr. Ramanathan held various positions within the US pharmaceutical industry, including Roche Vitamins Inc., Inhale Therapeutics (now Nektar Therapeutics), Alpharma and Cardinal Health. His professional experience and expertise ranges from R&D, process development, regulatory affairs and operations, as well as management of projects through development, regulatory filing and commercialization.